Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Erste Sparinvest - ESPA Stock Biotec

+ Add to Watchlist

BIOTECA:AV

454.34 EUR 8.56 1.85%

As of 00:59:30 ET on 01/28/2015.

Snapshot for Erste Sparinvest - ESPA Stock Biotec (BIOTECA)

Year To Date: +15.65% 3-Month: +27.80% 3-Year: +46.97% 52-Week Range: 249.33 - 462.90
1-Month: +15.84% 1-Year: +63.09% 5-Year: +35.88% Beta vs MIGUBTEC: 0.89

Mutual Fund Chart for BIOTECA

No chart data available.
  • BIOTECA:AV 454.34
  • 1M
  • 1Y
Interactive BIOTECA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIOTECA

ESPA Stock Biotec is an open-end investment fund incorporated in Austria. The Fund's objective is long-term capital growth. The Fund invests primarily in equity securities issued by larger biotechnology companies located in the United States, Europe and the Asian Pacific Region. The Fund invests approximately 70% of assets in the US, 25% in Europe and the remainder in Asia.

Inception Date: 04-17-2000 Telephone: +43 (0) 50100-0
Managers: HARALD KOBER
Web Site: www.erste-am.com

Fundamentals for BIOTECA

NAV (on 2015-01-28) 454.34
Assets (M) (on 2015-01-28) 193.39
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for BIOTECA

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2014-06-12) 3.62
Dividend Yield (ttm) 0.80

Fees & Expenses for BIOTECA

Front Load 4.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BIOTECA

Filing Date: 11/28/2014
Name Position Value % of Total
Celgene Corp 159,000 14,345,223 9.149%
Amgen Inc 93,500 12,339,318 7.870%
Regeneron Pharmaceuticals Inc 34,240 11,407,572 7.276%
Gilead Sciences Inc 137,500 11,049,353 7.047%
Biogen Idec Inc 43,200 10,553,655 6.731%
Vertex Pharmaceuticals Inc 77,950 7,206,386 4.596%
Alexion Pharmaceuticals Inc 42,150 6,575,690 4.194%
Illumina Inc 35,670 5,484,175 3.498%
Mylan Inc/PA 112,620 5,289,256 3.373%
BioMarin Pharmaceutical Inc 68,450 4,901,703 3.126%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil